Monday, September 13, 2021
Thursday, September 9, 2021
Investor Ideas #Potcasts 603, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (OTCQX: $VLNCF), (CSE: $BHSC.C), (TSXV: $N.V) (OTC: $NXTTF)
Investor Ideas #Potcasts 603, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (OTCQX: $VLNCF), (CSE: $BHSC.C), (TSXV: $N.V) (OTC: $NXTTF)
Delta, Kelowna, BC, September 9, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/090921-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/09091VLNS-BHSC-N-NXTTF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) today announced a white label partnership with Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), a leading, technology-powered, cannabis retailer with over 90 corporate-owned stores in Alberta, British Columbia, Manitoba, Ontario, Saskatchewan, and Yukon Territory. Under the terms of the agreement, Valens will manufacture Fire & Flower's Revity CBD oil for distribution in Ontario, Manitoba, and Saskatchewan with the potential to expand into additional provincial and territorial markets where permitted and agreed.
Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company, said,
"Fire & Flower is one of the leading cannabis retailers in Canada with a wide reach in this rapidly growing market. We admire their focus on consumer education and best-in-class retailing and are proud to partner with them for the first time to get high-quality wellness-focused products in the hands of Canadian consumers. This strategic relationship allows us to strengthen and expand our wellness-focused manufacturing portfolio and provides the opportunity to further our partnership with one of the largest cannabis retailers in the country."
Revity CBD oil will be formulated with Valens' proprietary processing methods to remove impurities and bring distinct cannabinoids to the forefront of the consumer experience. Each product includes an integrated dispenser to ensure consistency with each use. The product focus of the Revity CBD line has been derived from key consumer insights in product formulation, target consumer segments, price and format in the Hifyre™ Digital Retail and Analytics Platform.
Trevor Fencott, Chief Executive Officer and President of Fire & Flower, added, "We are proud to introduce our Revity CBD Oil in partnership with Valens and are confident that they will meet the experience and quality expectations of Canadian consumers. Valens' proven manufacturing excellence and experience producing high-quality wellness products made them a clear choice to help us continue to supply the evolving CBD market in Canada."
BioHarvest Sciences Inc. (CSE: BHSC) announced that the new manufacturing facility in Israel has successfully met the Israeli Ministry of Health's ISO9001 and ISO22000 (HACCP) certification requirements ahead of time. The ISO9001 certification covers internationally recognized standards for quality assurance and management, and the ISO22000 (HACCP) certification ensures that the required quality control and quality management systems are in place across the end-to-end manufacturing process to ensure the highest product safety levels. These 2 certifications are critical steps required prior to obtaining the GMP (Good Manufacturing Practices) certification from the Israeli Ministry of Health.
Despite the challenges caused by COVID19 to the global supply chain, this factory was built in 12 months. The facility will have the capacity to produce over 20 tons/year of VINIA® as well as other polyphenol-based products the Company has in its innovation pipeline. Pilot production of VINIA® in the new facility is expected to begin by the end of September 2021, and the capacity will be steadily increased each month to meet the growing demands of VINIA®'s D2C and B2B business in Israel, USA, and other global markets.
Kobi Rosenzweig, VP of Operations at BioHarvest Sciences, said, "I am delighted with the Company's ability to successfully pass the internationally recognized stringent quality requirements on its first attempt. Considering the speed at which this factory was built, this achievement is a testimony to the quality of the team and the ingenuity of the BioFarming technology. I thank our manufacturing partner Sugart and especially Ori Hahn, their CEO, for all the efforts exerted to deliver on such an aggressive schedule."
"The manufacturing arm of BioHarvest is an integral part of the Company's biotech vision," said Ilan Sobel, CEO of BioHarvest Sciences. "As a biotech innovator we will continue to develop and manufacture new products across multiple verticals. We have implemented the industrial manufacturing blueprint of our BioFarming technology in 12 months. This accomplishment gives me enormous confidence in our ability to scale our technology as we add on new verticals, (as in the case of Cannabis), and to build manufacturing plants closer to local markets such as North America, if required."
Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF) announced a corporate update including that the board has approved a name change from Namaste Technologies Inc. Trading of the Company’s common shares under its updated ticker symbol (“LFST”) is expected to commence on the TSX Venture Exchange (the “TSXV”), at market opening on or about September 15, 2021.
“Lifeist seeks to be a bold and disruptive wellness company, striving to connect humanity with safe, innovative and often daring pathways to individual definitions of wellness,” said Meni Morim, CEO of Lifeist. “The Lifeist rebrand speaks to ‘Higher Living’, resonating with a multi-billion dollar global market of consumers seeking to unlock their extraordinary. It’s an exciting time for the Company and its continued evolution to wellness as we look forward to complimenting the Company’s current portfolio of wellness of cannabis, hemp derived CBD and accessories, by delivering on our promise to establish a nutraceuticals division by the end of Q4, 2021.”
Visit the Company’s new website to learn more about Lifeist: https://lifeist.com.
Within the Lifeist portfolio of wellness interests lies the UK wellness website everyonedoesit.co.uk. Lifeist is pleased to announce expansion of its product offering to include hemp derived CBD products. Lifeist seeks to tap into the second largest global market for hemp-derived CBD estimated to generate £700 million in annual sales for 2021 according to the Association for the Cannabinoid Industry and Centre for Medicinal Cannabis.
Greenline POS, Canada's fully-compliant cannabis retail point-of-sale (POS) software, today announced a live menu integration with Weedmaps, a leading online listings marketplace for cannabis consumers and businesses.
Greenline's live menu integration will enable clients' product menus to be updated in real time on Weedmaps, eliminating pain points experienced with having to update multiple menus across platforms and resulting in a more seamless customer experience. To ensure that customers have the most up-to-date information, clients' POS menus will regularly be scanned to check for any recent changes. If any changes are detected, their Weedmaps menu will automatically be updated to be in sync with their POS menu.
"It is critical for cannabis retailers to have a wide-reaching digital presence to provide the best possible consumer experience." says Albert Kim, Chief Executive Officer of Greenline POS. "We're excited to work with Weedmaps to provide online menu functionality for all of our customers."
The integration will always be working in the background, but businesses will still have the capability to update their Weedmaps menu from the Weedmaps platform, allowing businesses to customize promotions and offerings for each platform. As well as managing menus, this integration will enable cannabis retailers to search brand catalogues and adjust pricing, product information, and product availability in real time.
"Inventory and menu management is a challenging task in the cannabis industry. Today's cannabis retailers must provide accurate product and pricing information, in real time for hundreds, if not thousands of menu items across multiple channels," says Justin Dean, Chief Technology Officer at Weedmaps. "By integrating Greenline technology with Weedmaps, our clients are able to optimize their inventory, provide a better customer experience, and allocate the time previously used for updating menus to growing their businesses."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Thursday, September 2, 2021
Wednesday, September 1, 2021
Investor Ideas #Potcasts 602, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (OTCQX: $VLNCF), (TSX: $HEXO.TO) (NASDAQ: HEXO), (NEO: MEDI), (CSE: $BHSC.C)
Investor Ideas #Potcasts 602, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (OTCQX: $VLNCF), (TSX: $HEXO.TO) (NASDAQ: HEXO), (NEO: MEDI), (CSE: $BHSC.C)
Delta, Kelowna, BC, September 1, 2021 (Investorideas.com Newswire) http://www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/090121-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/09011VLNS-HEXO-MEDI-BHSC.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
BioHarvest Sciences Inc. (CSE: BHSC) announced that it has successfully scaled its Cannabis cells with trichomes production by a factor of 250x and it is now growing Cannabis in medium-scale bioreactors, paving the way for its next scale-up milestone, where it will reach industrial-scale production. The next milestone, combined with the drying and measurement standards being concurrently developed, would constitute the successful completion of the Company's Cannabis development program.
Moving to the medium-scale bioreactors stage is not only a critical milestone in the scale-up and the proof of the capability of the BioFarming technology to produce Cannabis biomass, but is also an integral part of the industrial process development itself. The next milestone of the development program is growing Cannabis trichomes in industrial size bioreactors.
"The R&D methodology and relentless efforts are paying off," said Dr. Yochi Hagay, CTO, and added, "We are happy to have reached such a critical milestone. The recently announced and proprietary development of the Amalgamated Trichomes Coral Structure (ATCS) has certainly enabled this scale-up progress. As described before, ATCS protects the Trichomes during the growth phase against the shear forces generated by the media fluid motion. Such motion is exacerbated as you increase the size of the bioreactor, and I am confident that ATCS will sustain the forces in the next size of bioreactors, which is the final industrial-scale step. I look forward to announcing the completion of the whole program soon."
The CEO, Ilan Sobel, said, "Our industry-leading plant cell biology team is on track to deliver on one of the most challenging plant biological missions of growing cells of Cannabis Trichomes in liquid media at an industrial scale. Completing this mission will pave the way to the commercialization of BioFarming based Cannabis and Hemp products, marking a major turning point for the mainstream adoption of Cannabis by the global food and health sectors. The ability to economically and sustainably produce consistent, clean and pure whole spectrum Cannabis is nothing short of a revolution for the industry."
Eitan Popper, Chairman of BHSC's board of advisors and former President and Co-Founder of MedReleaf, stated, "BHSC's R&D team is making meaningful progress every month in the commercial scale-up of their Cannabis production. It is important to note that the most challenging part of the scale-up process is the transition from lab/bench scale to small-scale bioreactors, and then to medium-scale bioreactors. We are eagerly looking forward to the next Cannabis milestone announcement, as we know that it will be meaningful."
KetamineOne Capital Limited (NEO: MEDI) (OTC: KONEF), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, announced that it has reached a commercial agreement with Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) for Cognetivity’s Integrated Cognitive Assessment to be deployed in Ketamine One’s clinics across North America. The Company and Cognetivity have also entered into a non-binding letter of intent to collaborate on mental health assessments and plan on conducting clinical trials within Ketamine One’s network of clinics.
Cognetivity is a technology company that has created a cognitive testing platform for use in medical, commercial and consumer environments. Pursuant to the terms of the Agreement, Ketamine One plans to deploy Cognetivity’s ICA across its network clinics to enable the long-term monitoring of cognitive performance in patients with treatment-resistant depression and post-traumatic stress disorder (“PTSD”). The ICA offers numerous benefits to clinicians, particularly in comparison to traditional, pen-and-paper-based tests. A computerized assessment that takes five minutes, the ICA is user-friendly and exhibits no learning effect upon repeat testing, making it perfectly suited to long-term monitoring.
The ICA is also highly sensitive to small changes in cognitive performance and, owing to its computerized nature, is capable of supporting remote, self-administered testing. Assessing individuals’ cognition over the course of their treatment will enable the measurement of treatment efficacy, while empowering patients to take charge of their wellbeing and providing clinicians with additional data to refine treatment and improve outcomes.
In addition to the ICA’s deployment in Ketamine One’s clinics, the LOI will see Cognetivity and Ketamine One collaborate on developing and validating next-generation mental health assessment tools to improve the lives of sufferers. The Company believes that Cognetivity offers a unique and technologically advanced assessment tool that can help standardize in clinic procedures and offer a powerful analytical element to Ketamine One’s digital therapeutic platform.
It is widely accepted that there is vast potential for improvement in the treatment of such conditions. According to the WHO, mental health disorders account for 28% of the global burden of disability-adjusted life years among non-communicable diseases – more than cardiovascular disease or cancer. Every year, more than 12 billion working days are lost due to mental health conditions, costing the global economy US$16 trillion in economic output between 2011 and 2030. The estimated addressable market size for anxiety disorder and depression treatments is US$238 billion.
HEXO Corp. (TSX: HEXO) (NASDAQ: HEXO) and 48North Cannabis Corp. announced that they have completed the previously announced arrangement, pursuant to which HEXO has acquired all of the issued and outstanding common shares of 48North by way of a court-approved plan of arrangement under the Canada Business Corporations Act
.
Under the terms of the Arrangement, each former shareholder of 48North is now entitled to receive 0.02366 of a common share in the capital of HEXO for each 48North Share held immediately prior to the completion of the Arrangement. It is anticipated that the 48North Shares will be de-listed from the TSX Venture Exchange as of the close of trading on or about September 2, 2021.
In order to receive the Consideration, registered holders of 48North Shares will be required to deposit their share certificate(s) representing 48North Shares, together with a duly completed letter of transmittal, with TSX Trust Company, the depositary under the Arrangement. Shareholders whose 48North Shares are registered in the name of a broker, dealer, bank, trust company or other nominee should contact their nominee regarding the receipt of the Consideration.
Further information about the Arrangement is set forth in the materials prepared by 48North in respect of the special meeting of 48North Shareholders held on August 17, 2021 (the "Meeting"), which were mailed to 48North Shareholders and filed under 48North's profile on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, announced that it has completed a transaction to acquire Verse Cannabis including all of the Verse intellectual property. This acquisition, and Valens' recently announced agreement to acquire Citizen Stash Cannabis Corp., positions Valens as a top tier cannabis licensed producer in the Canadian industry by total provincial listings and market share.
Since launching in August 2020, Verse has emerged as a leading cannabis brand with a wide-ranging portfolio that spans all major product categories. Verse has been a pioneer in the value segment starting with its Tropic Lemon 510 thread vape cartridges (including one of the first 1.0g cartridges on the market) and continuing with the recent launch of BC God Bud 28g offering. Today, Verse boasts a number of innovative products in its portfolio such as the Sour Medley and Baked Apple Soft Chews, Double Chocolate Brownie, THC and CBD SoRSE-based drops and the Rapid Tropical Rush beverage to name a few. With over 90 provincial listings across 7 provinces and territories today, Verse offers a wide selection of high-quality products providing consumers an array of cannabis consumption experiences without the uncomfortably high price point. Valens aims to leverage Verse products as its lead value-focused offering within its brand portfolio.
Tyler Robson, Chief Executive Officer and Chair of the Board of The Valens Company, said, "The acquisitions of Verse and Citizen Stash were motivated by an underlying desire to become an ally to both our customers and consumers. We believe in creating best-in-class products that consumers deserve in the right way, without ever cutting corners. Whether it's medical or recreational, local or international, third-party owned brands or Valens owned brands, we're pursuing purity in extraction, formulation, product development and testing to bring the benefits of cannabis to the world. The expanded platform we have built at Valens is now positioned to better serve current and future customers and consumers through unique product offerings at attractive price points while maximizing shareholder value through Valens branded products."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Subscribe to:
Posts (Atom)